| Record Information |
|---|
| Version | 1.0 |
|---|
| Created at | 2020-03-18 23:24:10 UTC |
|---|
| Updated at | 2020-12-07 19:07:04 UTC |
|---|
| CannabisDB ID | CDB000084 |
|---|
| Secondary Accession Numbers | Not Available |
|---|
| Cannabis Compound Identification |
|---|
| Common Name | Safranal |
|---|
| Description | Safranal belongs to the class of organic compounds known as organic oxides which contain an oxide group. Safranal is a neutral compound. Safranal is a component of saffron (PMID: 28705037 ), the spice made from drying the stigmas and styles of crocus flowers (Crocus sativus). Safranal, the constituent primarily responsible for the aroma of saffron, has a sweet, fresh, and herbal taste and is a flavouring ingredient. Safranal has been detected in cauliflowers, cumin seeds, elderberry, figs, lemon, rooibos, saffrons, wolfberry, and tea leaf making safranal a potential biomarker for the consumption of these foods. Safranal is found in cannabis plants (PMID:6991645 ). Safranal is an effective anticonvulsant (PMID: 29609687 ) shown to act as an agonist at the gamma aminobutyric acid (GABA)A-benzodiazepine receptor complex (PMID: 16707256 ). Safranal also exhibits high antioxidant and free radical scavenging activity (PMID: 16317646 ), along with cytotoxicity towards cancer cells in vitro (PMID: 8620447 ). It has also been shown to have antidepressant properties (PMID: 15341662 ). |
|---|
| Structure | |
|---|
| Synonyms | | Value | Source |
|---|
| (2,6,6-Trimethylcyclohexa-1,3-dienyl)methanal | ChEBI | | 1,1,3-Trimethyl-2-formylcyclohexa-2,4-diene | ChEBI | | 2,6,6-Trimethyl-1,3-cyclohexadiene-1-carboxaldehyde | ChEBI | | 2,6,6-Trimethylcyclohexa-1,3-dienyl methanal | ChEBI | | Dehydro-beta-cyclocitral | ChEBI | | Dehydro-b-cyclocitral | Generator | | Dehydro-β-cyclocitral | Generator | | 1-Formyl-2,6,6-trimethyl-1,3-cyclohexadiene | HMDB | | 2,3-dihydro-2,2,6-Trimethylbenzaldehyde | HMDB | | 2,6,6-Trimethyl-1,3-cyclohexadienal | HMDB | | 2,6,6-Trimethyl-1,3-cyclohexadiene-1-carbaldehyde | HMDB | | 2,6,6-Trimethyl-1,3-cyclohexadienecarboxaldehyde, 9ci | HMDB | | FEMA 3389 | HMDB |
|
|---|
| Chemical Formula | C10H14O |
|---|
| Average Molecular Weight | 150.22 |
|---|
| Monoisotopic Molecular Weight | 150.1045 |
|---|
| IUPAC Name | 2,6,6-trimethylcyclohexa-1,3-diene-1-carbaldehyde |
|---|
| Traditional Name | safranal |
|---|
| CAS Registry Number | 116-26-7 |
|---|
| SMILES | CC1=C(C=O)C(C)(C)CC=C1 |
|---|
| InChI Identifier | InChI=1S/C10H14O/c1-8-5-4-6-10(2,3)9(8)7-11/h4-5,7H,6H2,1-3H3 |
|---|
| InChI Key | SGAWOGXMMPSZPB-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as organic oxides. These are organic compounds containing an oxide group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic oxygen compounds |
|---|
| Class | Organic oxides |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Organic oxides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aldehyde
- Aliphatic homomonocyclic compound
|
|---|
| Molecular Framework | Aliphatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
|
| Disposition | Route of exposure: Source: Biological location: |
|---|
| Role | Industrial application: Biological role: |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | < 25 °C | Not Available | | Boiling Point | 70 °C at 1 mmHg | Wikipedia | | Water Solubility | Not Available | Not Available | | logP | Not Available | Not Available |
|
|---|
| Predicted Properties | [] |
|---|
| Spectra |
|---|
| EI-MS/GC-MS | | Type | Description | Splash Key | View |
|---|
| Predicted GC-MS | Safranal, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-0kg9-2900000000-b082ebe4ee4447dc7980 | Spectrum | | Predicted GC-MS | Safranal, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Safranal, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum |
|
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0udi-0900000000-b34ca14deaad2e3be8c4 | 2016-08-03 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0uxr-9700000000-317a87cd8595a79b42d0 | 2016-08-03 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0gb9-9100000000-2993b4b7b24364148faf | 2016-08-03 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0002-0900000000-e83c23e4fe0dedd738e7 | 2016-08-03 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0002-0900000000-648f823a03c6712751e0 | 2016-08-03 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-05ng-8900000000-b0e87ace4983e8eca515 | 2016-08-03 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-00di-0900000000-b7cb4601ae2fb08997c1 | 2021-09-24 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-00dj-0900000000-449dca9897e0f3209324 | 2021-09-24 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0a4i-0900000000-861947f0491f909a2588 | 2021-09-24 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0zfr-4900000000-f591f9acd9c148c93dd0 | 2021-09-24 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0a4i-9800000000-066e7f2d59fb906577f8 | 2021-09-24 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0ar0-9300000000-c8eb85059ddf025ee54a | 2021-09-24 | View Spectrum |
|
|---|
| NMR | Not Available |
|---|
| Pathways |
|---|
| Pathways | Not Available |
|---|
| Protein Targets |
|---|
| Enzymes | Not Available |
|---|
| Transporters | |
| Gamma-aminobutyric acid receptor subunit alpha-1 | GABRA1 | 5q34-q35 | P14867 | details | | Gamma-aminobutyric acid receptor subunit alpha-2 | GABRA2 | 4p12 | P47869 | details |
|
|---|
| Metal Bindings | Not Available |
|---|
| Receptors | |
| Gamma-aminobutyric acid type B receptor subunit 1 | GABBR1 | 6p21.31 | Q9UBS5 | details | | Gamma-aminobutyric acid receptor subunit alpha-1 | GABRA1 | 5q34-q35 | P14867 | details | | Gamma-aminobutyric acid receptor subunit alpha-2 | GABRA2 | 4p12 | P47869 | details | | Taste receptor type 1 member 3 | TAS1R3 | 1p36.33 | Q7RTX0 | details | | Taste receptor type 1 member 2 | TAS1R2 | 1p36.13 | Q8TE23 | details |
|
|---|
| Transcriptional Factors | Not Available |
|---|
| Concentrations Data |
|---|
| Not Available |
|---|
| External Links |
|---|
| HMDB ID | HMDB0036061 |
|---|
| DrugBank ID | Not Available |
|---|
| Phenol Explorer Compound ID | Not Available |
|---|
| FoodDB ID | FDB014884 |
|---|
| KNApSAcK ID | C00035737 |
|---|
| Chemspider ID | 55000 |
|---|
| KEGG Compound ID | C17062 |
|---|
| BioCyc ID | CPD-8669 |
|---|
| BiGG ID | Not Available |
|---|
| Wikipedia Link | Safranal |
|---|
| METLIN ID | Not Available |
|---|
| PubChem Compound | 61041 |
|---|
| PDB ID | Not Available |
|---|
| ChEBI ID | 53169 |
|---|
| References |
|---|
| General References | - Turner CE, Elsohly MA, Boeren EG: Constituents of Cannabis sativa L. XVII. A review of the natural constituents. J Nat Prod. 1980 Mar-Apr;43(2):169-234. doi: 10.1021/np50008a001. [PubMed:6991645 ]
- Rameshrad M, Razavi BM, Hosseinzadeh H: Saffron and its derivatives, crocin, crocetin and safranal: a patent review. Expert Opin Ther Pat. 2018 Feb;28(2):147-165. doi: 10.1080/13543776.2017.1355909. Epub 2017 Jul 18. [PubMed:28705037 ]
- Bo-Qiang L, Si-Tong Z, Zu-Yuan L, Wan-Yun N, Bin C, Yuan L, Xuyun L, Liangen M, You-Chao C, Xin-Zhen Y, Zhong C, Xiao-Ying Y, Wei-Wei H: Safranal carried by nanostructured lipid vehicles inhibits generalized epilepsy in mice. Pharmazie. 2018 Apr 2;73(4):207-212. doi: 10.1691/ph.2018.7310. [PubMed:29609687 ]
- Hosseinzadeh H, Sadeghnia HR: Protective effect of safranal on pentylenetetrazol-induced seizures in the rat: involvement of GABAergic and opioids systems. Phytomedicine. 2007 Apr;14(4):256-62. doi: 10.1016/j.phymed.2006.03.007. Epub 2006 May 16. [PubMed:16707256 ]
- Assimopoulou AN, Sinakos Z, Papageorgiou VP: Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents. Phytother Res. 2005 Nov;19(11):997-1000. doi: 10.1002/ptr.1749. [PubMed:16317646 ]
- Escribano J, Alonso GL, Coca-Prados M, Fernandez JA: Crocin, safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro. Cancer Lett. 1996 Feb 27;100(1-2):23-30. doi: 10.1016/0304-3835(95)04067-6. [PubMed:8620447 ]
- Akhondzadeh S, Fallah-Pour H, Afkham K, Jamshidi AH, Khalighi-Cigaroudi F: Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816]. BMC Complement Altern Med. 2004 Sep 2;4:12. doi: 10.1186/1472-6882-4-12. [PubMed:15341662 ]
|
|---|